Major Pharmas To Collaborate In Non-Profit Initiative To Resolve Clinical Development Hurdles

19 Sep 2012

Called TransCelerate BioPharma, the initiative funded by 10 big drug firms will work to develop uniform clinical data standards and certification for trial sites and investigators, with deliverables expected by mid-2013.

Transform. Accelerate. These are the apparent goals of a collaborative effort to fund and staff a non-profit that will work to alleviate bottlenecks in the pharmaceutical R&D process. Unveiled Sept. 18, TransCelerate BioPharma Inc. will strive to identify and solve common drug-development challenges, improve clinical trial quality and ultimately bring new products to market more quickly.

TransCelerate acting CEO Garry Neil, former corporate VP, science & technology, at Johnson & Johnson, said the primary issues...